ver 15 1 Search Results


ver 15 1  (STATA Corporation)
99
STATA Corporation ver 15 1
Ver 15 1, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ver+15+1/ppr0386559-82-6-7?v=STATA+Corporation
Average 99 stars, based on 1 article reviews
ver 15 1 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
mysql/mariadb  (MariaDB Corporation)
90
MariaDB Corporation mysql/mariadb
Mysql/Mariadb, supplied by MariaDB Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ver+15+1/pmc09332048-224-5-3?v=MariaDB+Corporation
Average 90 stars, based on 1 article reviews
mysql/mariadb - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
replicase genes  (DNASTAR)
99
DNASTAR replicase genes
Fig. 3. PCV2 vaccination and challenge induces antigen-specific IFN-c secreting cells (PBMC). Pigs were randomly assigned to one of four treatment groups designated T (for treatment) 01–04, n = 24/group. T01, control, received the placebo control, saline; T02 received 2 doses of the cPCV2a/cPCV2b/MH vaccine; T03 received 1 dose of the cPCV2a/ cPCV2b/MH vaccine; and T04 received 2 doses of the rPCV2a/MH vaccine as described in the Study Design table. Pigs were vaccinated (V1 and V2) and challenged (C) on the indicated study days, per treatment. Recall antigen was one of two <t>replicase</t> peptide pools (16-mers, overlapping by 12 amino acids) (A, B) or a set of peptides containing unique T cell epitopes found in PCV2d, but not PCV2a (C). Results expressed as spot forming cells (SFC) per 106 PBMC. Significant differences between groups at each time point are indicated by letter. Groups with different letter designations at each time point are statistically different from each other. Data points without letters, bounded by boxes or with overlapping symbols are not significantly different from each other.
Replicase Genes, supplied by DNASTAR, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ver+15+1/pm34420789-94-18-25?v=DNASTAR
Average 99 stars, based on 1 article reviews
replicase genes - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
jmp statistical analysis tool  (SAS institute)
90
SAS institute jmp statistical analysis tool
Fig. 3. PCV2 vaccination and challenge induces antigen-specific IFN-c secreting cells (PBMC). Pigs were randomly assigned to one of four treatment groups designated T (for treatment) 01–04, n = 24/group. T01, control, received the placebo control, saline; T02 received 2 doses of the cPCV2a/cPCV2b/MH vaccine; T03 received 1 dose of the cPCV2a/ cPCV2b/MH vaccine; and T04 received 2 doses of the rPCV2a/MH vaccine as described in the Study Design table. Pigs were vaccinated (V1 and V2) and challenged (C) on the indicated study days, per treatment. Recall antigen was one of two <t>replicase</t> peptide pools (16-mers, overlapping by 12 amino acids) (A, B) or a set of peptides containing unique T cell epitopes found in PCV2d, but not PCV2a (C). Results expressed as spot forming cells (SFC) per 106 PBMC. Significant differences between groups at each time point are indicated by letter. Groups with different letter designations at each time point are statistically different from each other. Data points without letters, bounded by boxes or with overlapping symbols are not significantly different from each other.
Jmp Statistical Analysis Tool, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ver+15+1/pmc09876887-273-17-20?v=SAS+institute
Average 90 stars, based on 1 article reviews
jmp statistical analysis tool - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
stata statistical software  (STATA Corporation)
99
STATA Corporation stata statistical software
Fig. 3. PCV2 vaccination and challenge induces antigen-specific IFN-c secreting cells (PBMC). Pigs were randomly assigned to one of four treatment groups designated T (for treatment) 01–04, n = 24/group. T01, control, received the placebo control, saline; T02 received 2 doses of the cPCV2a/cPCV2b/MH vaccine; T03 received 1 dose of the cPCV2a/ cPCV2b/MH vaccine; and T04 received 2 doses of the rPCV2a/MH vaccine as described in the Study Design table. Pigs were vaccinated (V1 and V2) and challenged (C) on the indicated study days, per treatment. Recall antigen was one of two <t>replicase</t> peptide pools (16-mers, overlapping by 12 amino acids) (A, B) or a set of peptides containing unique T cell epitopes found in PCV2d, but not PCV2a (C). Results expressed as spot forming cells (SFC) per 106 PBMC. Significant differences between groups at each time point are indicated by letter. Groups with different letter designations at each time point are statistically different from each other. Data points without letters, bounded by boxes or with overlapping symbols are not significantly different from each other.
Stata Statistical Software, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ver+15+1/pm37076098-110-7-12?v=STATA+Corporation
Average 99 stars, based on 1 article reviews
stata statistical software - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
jmp ver 15.1.0  (SAS institute)
90
SAS institute jmp ver 15.1.0
Fig. 3. PCV2 vaccination and challenge induces antigen-specific IFN-c secreting cells (PBMC). Pigs were randomly assigned to one of four treatment groups designated T (for treatment) 01–04, n = 24/group. T01, control, received the placebo control, saline; T02 received 2 doses of the cPCV2a/cPCV2b/MH vaccine; T03 received 1 dose of the cPCV2a/ cPCV2b/MH vaccine; and T04 received 2 doses of the rPCV2a/MH vaccine as described in the Study Design table. Pigs were vaccinated (V1 and V2) and challenged (C) on the indicated study days, per treatment. Recall antigen was one of two <t>replicase</t> peptide pools (16-mers, overlapping by 12 amino acids) (A, B) or a set of peptides containing unique T cell epitopes found in PCV2d, but not PCV2a (C). Results expressed as spot forming cells (SFC) per 106 PBMC. Significant differences between groups at each time point are indicated by letter. Groups with different letter designations at each time point are statistically different from each other. Data points without letters, bounded by boxes or with overlapping symbols are not significantly different from each other.
Jmp Ver 15.1.0, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ver+15+1/pm38367656-140-21-24?v=SAS+institute
Average 90 stars, based on 1 article reviews
jmp ver 15.1.0 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
kcnk6 nm 004823 human over expression lysate  (OriGene)
N/A
KCNK6 HEK293T cell transient overexpression lysate as WB positive control
   Buy from Supplier
znf146 nm 007145 human over expression lysate  (OriGene)
N/A
ZNF146 HEK293T cell transient overexpression lysate as WB positive control
   Buy from Supplier
arl6ip6 overexpression lysate denatured  (Novus Biologicals)
N/A
   Buy from Supplier
cathepsin h overexpression lysate denatured  (Novus Biologicals)
N/A
   Buy from Supplier
serpin a1 alpha 1 antitrypsin overexpression lysate native  (Novus Biologicals)
N/A
   Buy from Supplier
kirrel 3 kirrel3 nm 001161707 human over expression lysate  (OriGene)
N/A
KIRREL3 HEK293T cell transient overexpression lysate as WB positive control
   Buy from Supplier

Image Search Results


Fig. 3. PCV2 vaccination and challenge induces antigen-specific IFN-c secreting cells (PBMC). Pigs were randomly assigned to one of four treatment groups designated T (for treatment) 01–04, n = 24/group. T01, control, received the placebo control, saline; T02 received 2 doses of the cPCV2a/cPCV2b/MH vaccine; T03 received 1 dose of the cPCV2a/ cPCV2b/MH vaccine; and T04 received 2 doses of the rPCV2a/MH vaccine as described in the Study Design table. Pigs were vaccinated (V1 and V2) and challenged (C) on the indicated study days, per treatment. Recall antigen was one of two replicase peptide pools (16-mers, overlapping by 12 amino acids) (A, B) or a set of peptides containing unique T cell epitopes found in PCV2d, but not PCV2a (C). Results expressed as spot forming cells (SFC) per 106 PBMC. Significant differences between groups at each time point are indicated by letter. Groups with different letter designations at each time point are statistically different from each other. Data points without letters, bounded by boxes or with overlapping symbols are not significantly different from each other.

Journal: Vaccine

Article Title: Cellular and humoral immunity following vaccination with two different PCV2 vaccines (containing PCV2a or PCV2a/PCV2b) and challenge with virulent PCV2d.

doi: 10.1016/j.vaccine.2021.08.013

Figure Lengend Snippet: Fig. 3. PCV2 vaccination and challenge induces antigen-specific IFN-c secreting cells (PBMC). Pigs were randomly assigned to one of four treatment groups designated T (for treatment) 01–04, n = 24/group. T01, control, received the placebo control, saline; T02 received 2 doses of the cPCV2a/cPCV2b/MH vaccine; T03 received 1 dose of the cPCV2a/ cPCV2b/MH vaccine; and T04 received 2 doses of the rPCV2a/MH vaccine as described in the Study Design table. Pigs were vaccinated (V1 and V2) and challenged (C) on the indicated study days, per treatment. Recall antigen was one of two replicase peptide pools (16-mers, overlapping by 12 amino acids) (A, B) or a set of peptides containing unique T cell epitopes found in PCV2d, but not PCV2a (C). Results expressed as spot forming cells (SFC) per 106 PBMC. Significant differences between groups at each time point are indicated by letter. Groups with different letter designations at each time point are statistically different from each other. Data points without letters, bounded by boxes or with overlapping symbols are not significantly different from each other.

Article Snippet: Table 2 shows sequence identity and divergence of PCV1 or PCV2 by type or PCV2-genotype specific capsid and replicase genes (Clustal W, MegAlign Ver 15.1.0, DNASTAR, Madison, WI, USA).

Techniques: Control, Saline